-

Biote CEO Terry S. Weber to Present at Jefferies Healthcare Conference

IRVING, Texas--(BUSINESS WIRE)--Biote Medical today announces that CEO Terry S. Weber will present at the Jefferies Virtual Healthcare Conference on June 3 at 9:30 a.m. Eastern time in Track 1. The video presentation will be live streamed, and conference attendees can register via the Jefferies portal.

Biote is the leader in bioidentical hormone optimization therapy for men and women and commercializes supporting supplements scientifically formulated to complement hormone performance. Under the leadership of Ms. Weber, Biote advocates for provider and patient access to bioidentical hormone replacement therapy (BHRT) and is committed to the highest standards of science, education, and research.

The presentation will be open to both audience questions and media, and a recording will be made available following the event.

The Jefferies Virtual Healthcare Conference gathers over 400 public and private health care companies and 3,000 leading executives, institutional investors, private equity investors and venture capitalists to address near- and long-term investment opportunities and discuss the current trends driving health care in the U.S. and internationally. Please direct registration questions to healthcareconference@jefferies.com.

About Biote Medical
Biote Medical is a hormone optimization company that has translated over 80 years of scientific insight into clinically-validated medical approaches that identify and treat imbalances in the production of hormones. Founded in 2009, the Irving, Texas, based company offers bioidentical hormone replacement pellet therapy to both men and women and supporting supplements scientifically formulated to complement hormone performance. By partnering with over 5,500 medical providers across the United States, Biote Medical is educating practitioners on the scientific evidence of the roles of hormones and supplements to support improved health, and on responsible treatment of patients. We are dedicated to helping patients live better, longer by changing the way health care is practiced on a global level.

Contacts

Liz DeForest, The Bliss Group for Biote
Biote@blissintegrated.com

Biote Medical


Release Versions

Contacts

Liz DeForest, The Bliss Group for Biote
Biote@blissintegrated.com

More News From Biote Medical

Nearly 40% of Women Say They were Misdiagnosed During Perimenopause, National Survey Reveals

IRVING, Texas--(BUSINESS WIRE)--A new national survey finds nearly 40% of women felt misdiagnosed during perimenopause, revealing major gaps in women’s healthcare....

Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division

IRVING, Texas--(BUSINESS WIRE)--Biote, a leading provider of hormone optimization, has announced the launch of a dedicated Men’s Health Division....

Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report

IRVING, Texas--(BUSINESS WIRE)--In a case study, a 54-year-old male patient with a spontaneous fracture and osteoporosis achieved an “almost complete recovery of osteoporosis” after one year of pelleted testosterone therapy and experienced improvements in quality of life and sleep apnea. The results of “Subcutaneous Testosterone Pellet Therapy for Reversal of Male Osteoporosis: A Review and Case Report” were published in the peer-reviewed medical journal “The Aging Male,” the official journal o...
Back to Newsroom